Embecta (EMBC) Stock Forecast: StockMap's 2-Week Call

EMBC stock forecast: StockMap's model leans Outperform on Embecta for the two weeks after the Nov 19 close, toward EMBC doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 1 of 6 two-week windows on EMBC since Aug 21; by chance, a call on the same dates was right 64% of the time.

Embecta last closed at $6.19, +1.64% on the session.

Against the IVW growth benchmark the position is +3.97% over the forecast window.

Embecta's market cap is $350.72M as of November 19, 2026.

Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 27 (too close to call).

Where EMBC sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 7 bullish and 8 bearish.

Agreement across those insights is 47%.

32 daily calls for EMBC so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Embecta in the 97th percentile on valuation and the 30th percentile on return on equity, where 100 is best.

Embecta is classified under Health Care / Health Care Equipment & Supplies.

StockMap tracks Embecta as the 80th largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.

On that composite Embecta ranks 3rd of 141 in the group, against a group median of -0.18.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 19, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Embecta (EMBC) — StockMap 2-week forecast & tracked accuracy